Shopping Cart
- Remove All
- Your shopping cart is currently empty
RO-9187 is an effective HCV virus replication inhibitor(IC50: 171 nM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | 107 € | 5 days | |
5 mg | 224 € | 5 days | |
50 mg | 684 € | 6-8 weeks | |
100 mg | 947 € | 6-8 weeks | |
1 mL x 10 mM (in DMSO) | 207 € | 5 days |
Description | RO-9187 is an effective HCV virus replication inhibitor(IC50: 171 nM). |
Targets&IC50 | HCV:171 nM |
In vitro | RO-9187 suppresses RNA synthesis by HCV polymerases from either HCV genotypes 1a and 1b or containing S96T or S282T point mutations with similar potencies, suggesting no cross-resistance with either R1479 or 2′-C-methyl nucleosides. RO-9187 is excellent substrates for deoxycytidine kinase and is phosphorylated with efficiencies up to 3-fold higher than deoxycytidine. The formation of RO-9187-TP increased in a time- and dose-dependent manner [1]. |
In vivo | Plasma exposures of RO-9187 in rats increase dose-dependently from 10 to 2000 mg/kg after oral administration. Plasma concentrations of RO-9187 (1.4 and 26 μM) are achieved in rats and dogs at the 10 mg/kg dose, respectively, with concentrations reaching up to 57 μM in rats at 2000 mg/kg/day[1]. |
Molecular Weight | 284.23 |
Formula | C9H12N6O5 |
Cas No. | 876708-03-1 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | H2O: 7.14 mg/mL (25.12 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
H2O
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.